Thyroidectomy without Radioiodine in Low- Risk Thyroid Cancer Reply

被引:0
作者
Leboulleux, Sophie [1 ]
Schlumberger, Martin-Jean [2 ]
Borget, Isabelle [2 ]
机构
[1] Hop Univ Geneve, Geneva, Switzerland
[2] Gustave Roussy, Villejuif, France
关键词
ABLATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2155 / 2155
页数:1
相关论文
共 50 条
  • [31] Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2*)
    Dietlein, M
    Dressler, J
    Farahati, J
    Grünwald, F
    Leisner, B
    Moser, E
    Reiners, C
    Schicha, H
    Schober, O
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2004, 43 (04): : 115 - 120
  • [32] Utility of FDG PET at the Initial Radioiodine Therapy in Differentiated Thyroid Cancer
    Matsuo, Mioko
    Baba, Shingo
    Hashimoto, Kazuki
    Isoda, Takuro
    Kitamura, Yoshiyuki
    Kogo, Ryunosuke
    Jiromaru, Rina
    Hongo, Takahiro
    Manako, Tomomi
    Nakagawa, Takashi
    ANTICANCER RESEARCH, 2023, 43 (01) : 183 - 190
  • [33] Is it necessary to reduce the radioiodine dose in patients with thyroid cancer and renal failure?
    Willegaignon, Jose
    Brito Ribeiro, Verena Pinto
    Sapienza, Marcelo
    Ono, Carla
    Watanabe, Tomoco
    Buchpiguel, Carlos
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (04) : 413 - 418
  • [34] INFLUENCE OF HYDROCHLOROTHIAZIDE ON URINARY EXCRETION OF RADIOIODINE IN PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Ignjatovic, V. D.
    Vukomanovic, V.
    Jeremic, M.
    Ignjatovic, V. S.
    Matovic, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2015, 11 (03) : 396 - 400
  • [35] RADIOTHERAPY Radioiodine in thyroid cancer-how to minimize side effects
    Reiners, Christoph
    Luster, Markus
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (08) : 432 - 434
  • [36] The Role of Routine Diagnostic Radioiodine Whole-Body Scintigraphy in Patients with High-Risk Differentiated Thyroid Cancer
    de Meer, Siegrid G.
    Vriens, Menno R.
    Zelissen, Pierre M.
    Rinkes, Inne H. Borel
    de Keizer, Bart
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (01) : 56 - 59
  • [37] Dynamic risk allows us to adequately select patients with differentiated thyroid cancer who do not require radioiodine treatment
    Abelleira, Erika
    Angela Penaloza, Mirna
    Jerkovich, Fernando
    Bueno, Fernanda
    Pitoia, Fabian
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (03): : 315 - 321
  • [38] APPLICATION OF POST-SURGICAL STIMULATED THYROGLOBULIN FOR RADIOIODINE REMNANT ABLATION SELECTION IN LOW-RISK PAPILLARY THYROID CARCINOMA
    Vaisman, Alon
    Orlov, Steven
    Yip, Jonathan
    Hu, Cindy
    Lim, Terence
    Dowar, Mark
    Freeman, Jeremy L.
    Walfish, Paul G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (06): : 689 - 698
  • [39] Characterization of Graves' disease development after partial thyroidectomy for thyroid cancer
    Wan, Huan
    Zhang, Yingqiang
    Chen, Yonghui
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (07) : 3168 - 3176
  • [40] Dosimetric dependencies on target geometry and size in radioiodine therapy for differentiated thyroid cancer
    Nilsson, Joachim N.
    Siikanen, Jonathan
    Lundgren, Catharina Ihre
    Ardenfors, Oscar
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2022, 99 : 68 - 72